Terms: = Prostate cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Treatment
2 results:
1. Apalutamide for patients with metastatic castrationsensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trial.
Chung BH; Huang J; Ye ZQ; He DL; Uemura H; Arai G; Kim CS; Zhang YY; Koroki Y; Jeong S; Mundle S; Triantos S; McCarthy S; Chi KN; Ye DW
Asian J Androl; 2022; 24(2):161-166. PubMed ID: 34259202
[TBL] [Abstract] [Full Text] [Related]
2. Incidence, Management, and Clinical Outcomes of prostate cancer in Kidney Transplant Recipients.
Haroon UH; Davis NF; Mohan P; Little DM; Smyth G; Forde JC; Power RE
Exp Clin Transplant; 2019 Jun; 17(3):298-303. PubMed ID: 30602361
[TBL] [Abstract] [Full Text] [Related]
